Cytokinetics EVP R&D Malik Fady Ibraham sells 3,500 shares valued at $214,830
CYTK•Cytokinetics EVP of Research & Development Malik Fady Ibraham exercised 3,500 shares at $7.80 each and sold them at $61.38 each on Oct. 6, 2026, for a reported value of $214,830.
1. Share transactions
Ibraham reported exercising and selling 3,500 Cytokinetics common shares on Oct. 6, 2026. After the transactions, he directly held 153,902 common shares and 19,886 non-qualified stock options.
